Unlicensed and off-label drug use in children before and after pediatric governmental initiatives
OBJECTIVES: Governmental agencies (US Food and Drug Administration and European
Medicines Agency) implemented initiatives to improve pediatric clinical research, starting in …
Medicines Agency) implemented initiatives to improve pediatric clinical research, starting in …
A new species of Homo from the Late Pleistocene of the Philippines
A hominin third metatarsal discovered in 2007 in Callao Cave (Northern Luzon, the Philippines)
and dated to 67 thousand years ago provided the earliest direct evidence of a human …
and dated to 67 thousand years ago provided the earliest direct evidence of a human …
A machine learning–based clinical decision support system to identify prescriptions with a high risk of medication error
J Corny, A Rajkumar, O Martin, X Dode… - Journal of the …, 2020 - academic.oup.com
Objective To improve patient safety and clinical outcomes by reducing the risk of prescribing
errors, we tested the accuracy of a hybrid clinical decision support system in prioritizing …
errors, we tested the accuracy of a hybrid clinical decision support system in prioritizing …
[HTML][HTML] Effectiveness of a 'do not interrupt'vest intervention to reduce medication errors during medication administration: a multicenter cluster randomized controlled …
…, A Vilfaillot, Y Bezie, G Perrin, M Berge, J Corny… - BMC nursing, 2021 - Springer
Background The use of a ‘do not interrupt’ vest during medication administration rounds is
recommended but there have been no controlled randomized studies to evaluate its impact …
recommended but there have been no controlled randomized studies to evaluate its impact …
[HTML][HTML] The first evidence for Late Pleistocene dogs in Italy
…, C Zanolli, A Tagliacozzo, R Fico, M Fedi, J Corny… - Scientific Reports, 2020 - nature.com
The identification of the earliest dogs is challenging because of the absence and/or mosaic
pattern of morphological diagnostic features in the initial phases of the domestication process…
pattern of morphological diagnostic features in the initial phases of the domestication process…
Intravenous immunoglobulin therapy in pediatric narcolepsy: a nonrandomized, open-label, controlled, longitudinal observational study
M Lecendreux, J Berthier, J Corny… - Journal of Clinical …, 2017 - jcsm.aasm.org
… Int J Pediatr Obes; 2011;65-6:325-331, 21916784. … 35 Busner J, Targum SDThe
clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont); …
clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont); …
Assessment of a hybrid decision support system using machine learning with artificial intelligence to safely rule out prescriptions from medication review in daily …
…, A Buronfosse, R Courseau, Y Bézie, J Corny - International Journal of …, 2022 - Springer
Background Medication review is time-consuming and not exhaustive in most French
hospitals. We routinely use an innovative hybrid decision support system using Artificial …
hospitals. We routinely use an innovative hybrid decision support system using Artificial …
Further analyses of the structural organization of Homo luzonensis teeth: Evolutionary implications
…, AS Mijares, O Kullmer, F Schrenk, J Corny… - Journal of Human …, 2022 - Elsevier
The species Homo luzonensis has recently been described based on a set of dental and
postcranial elements found at Callao Cave (Northern Luzon, Philippines) and dated to at least …
postcranial elements found at Callao Cave (Northern Luzon, Philippines) and dated to at least …
Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital
OBJECTIVE: To assess unlicensed and off-label drug use in a tertiary care paediatric hospital
in Canada on a single day. METHODS: A cross-sectional study in a tertiary care paediatric …
in Canada on a single day. METHODS: A cross-sectional study in a tertiary care paediatric …
[HTML][HTML] Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
A Costantini, J Corny, V Fallet, S Renet… - ERJ open …, 2018 - Eur Respiratory Soc
Nivolumab for the treatment of advanced nonsmall cell lung cancer (NSCLC) evaluated in
phase III trials showed 50% progression at first evaluation, but better overall survival (OS), …
phase III trials showed 50% progression at first evaluation, but better overall survival (OS), …